Sedana Medical AB (SEDANA) - Total Assets
Based on the latest financial reports, Sedana Medical AB (SEDANA) holds total assets worth Skr937.51 Million SEK (≈ $100.89 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sedana Medical AB - Total Assets Trend (2015–2025)
This chart illustrates how Sedana Medical AB's total assets have evolved over time, based on quarterly financial data. Also see Sedana Medical AB (SEDANA) market capitalisation for the company's overall valuation and market capitalisation.
Sedana Medical AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Sedana Medical AB's total assets of Skr937.51 Million consist of 18.2% current assets and 81.8% non-current assets. Review SEDANA total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 9.5% |
| Accounts Receivable | Skr40.89 Million | 4.3% |
| Inventory | Skr37.87 Million | 4.0% |
| Property, Plant & Equipment | Skr9.76 Million | 1.0% |
| Intangible Assets | Skr744.93 Million | 78.1% |
| Goodwill | Skr25.28 Million | 2.7% |
Asset Composition Trend (2015–2025)
This chart illustrates how Sedana Medical AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Sedana Medical AB stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sedana Medical AB's current assets represent 18.2% of total assets in 2025, a decrease from 89.2% in 2015.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, down from 25.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 80.0% of total assets, an increase from 6.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 78.1% of total assets.
Sedana Medical AB Competitors by Total Assets
Key competitors of Sedana Medical AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €408.98 Million |
|
Somnomed Ltd
AU:SOM
|
Australia | AU$79.90 Million |
Sedana Medical AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.89 | 4.56 | 6.89 |
| Quick Ratio | 1.94 | 3.71 | 6.61 |
| Cash Ratio | 0.00 | 0.00 | 5.95 |
| Working Capital | Skr85.55 Million | Skr168.63 Million | Skr258.67 Million |
Sedana Medical AB - Advanced Valuation Insights
This section examines the relationship between Sedana Medical AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.18 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -6.4% |
| Total Assets | Skr954.46 Million |
| Market Capitalization | $106.05 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sedana Medical AB's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sedana Medical AB's assets decreased by 6.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sedana Medical AB (2015–2025)
The table below shows the annual total assets of Sedana Medical AB from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr954.46 Million ≈ $102.72 Million |
-6.37% |
| 2024-12-31 | Skr1.02 Billion ≈ $109.70 Million |
+0.53% |
| 2023-12-31 | Skr1.01 Billion ≈ $109.13 Million |
-6.24% |
| 2022-12-31 | Skr1.08 Billion ≈ $116.40 Million |
-7.36% |
| 2021-12-31 | Skr1.17 Billion ≈ $125.65 Million |
+94.57% |
| 2020-12-31 | Skr600.10 Million ≈ $64.58 Million |
+1.15% |
| 2019-12-31 | Skr593.25 Million ≈ $63.84 Million |
+156.21% |
| 2018-12-31 | Skr231.55 Million ≈ $24.92 Million |
+76.25% |
| 2017-12-31 | Skr131.38 Million ≈ $14.14 Million |
+473.62% |
| 2016-12-31 | Skr22.90 Million ≈ $2.46 Million |
+84.69% |
| 2015-12-31 | Skr12.40 Million ≈ $1.33 Million |
-- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the c… Read more